by The global Spatial OMICS market size was estimated to be around US$ 251.3 million in 2022. It is projected to reach US$ 685.12 million by 2032, indicating a CAGR of 10.60% from 2023 to 2032.
Key Takeaways
- North America contributed more than 45% of revenue share in 2022.
- Asia-Pacific region is estimated to expand the fastest CAGR between 2023 and 2032.
- By Application, the Diagnostics segment has held the largest market share of 39% in 2022.
- By Application, the Translation Research segment is anticipated to grow at a remarkable CAGR of 12.8% between 2023 and 2032.
- By Solution Type, the Instruments segment generated over 42% of revenue share in 2022.
- By Solution Type, the Software segment is expected to expand at the fastest CAGR over the projected period.
- By Sample, the DNA segment generated over 52% of revenue share in 2022.
- By Sample, the RNA segment is expected to expand at the fastest CAGR over the projected period.
- By End-user, the Biopharmaceutical & Biotechnological Companies segment had the largest market share of 48% in 2022.
- By End-user, the Academic and Research Institutions segment is expected to expand at the fastest CAGR over the projected period.
The Spatial OMICS Market refers to the industry related to spatial genomics and other OMICS technologies. “Spatial genomics” involves studying genetic information within its spatial context in tissues or cells, providing a more comprehensive understanding of biological processes. This market likely includes technologies and tools that enable researchers to analyze and visualize the spatial organization of biomolecules, such as genes and proteins, within biological samples. Applications may range from understanding disease mechanisms to drug discovery and personalized medicine. The market is driven by the increasing demand for advanced molecular analysis techniques in the field of genomics.
Get a Sample: https://www.precedenceresearch.com/sample/3517
Growth Factors
The Spatial OMICS market has witnessed substantial growth in recent years, with a notable surge in demand driven by advancements in omics technologies and their application in spatially resolved analysis. The Growth Factor for Spatial OMICS can be attributed to its ability to provide a comprehensive understanding of the spatial organization of biological molecules within tissues. This technology allows researchers to investigate complex biological systems at a single-cell resolution, offering insights into the spatial distribution of genes, proteins, and other biomolecules. The integration of spatial information with traditional omics data enhances our understanding of cellular heterogeneity and interactions within tissues, thereby contributing to advancements in fields such as cancer research, neuroscience, and developmental biology. As the Spatial OMICS market continues to evolve, innovations and collaborations within the scientific community are expected to further propel its growth, opening new avenues for diagnostic and therapeutic applications.
Spatial OMICS Market Scope
| Report Coverage | Details |
| Growth Rate from 2023 to 2032 | CAGR of 10.60% |
| Market Size in 2023 | USD 276.68 Million |
| Market Size by 2032 | USD 685.12 Million |
| Largest Market | North America |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Segments Covered | By Application, By Solution Type, By Sample, and By End Users |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Read More: Pet Food and Supplements Market Size to Garner USD 179.18 Billion by 2032
North America has held the largest revenue share of 45% in 2022. The North American spatial OMICS market showcases a trend of substantial growth driven by extensive research and development initiatives. Leading academic institutions, biotechnology companies, and pharmaceutical firms are heavily investing in this technology, particularly in precision diagnostics and drug discovery. The region benefits from a robust infrastructure for data analytics and interdisciplinary collaborations, further accelerating advancements in spatial OMICS applications.
Europe is estimated to observe the fastest expansion. In Europe, the spatial OMICS market is characterized by a strong emphasis on standardization and regulatory compliance. The region is focusing on developing standardized protocols for data collection and analysis, ensuring data accuracy and reproducibility. This commitment to standardization is crucial for fostering trust in spatial OMICS data and its adoption in clinical and regulatory settings. Additionally, European researchers are actively exploring applications in neuroscience and cancer research, contributing to the market’s steady growth.
Recent Developments
- In 2023, OMAPiX, a spatial omics services provider, has forged collaborations with Vizgen, Resolve Biosciences, and Ultivue, Inc. They will utilize cutting-edge technologies to deliver standardized, high-quality spatial transcriptomic and proteomic data. These partnerships aim to accelerate drug development and life science research by providing valuable insights to customers.
- In 2023, Bio-Techne and Lunaphore are forming a strategic alliance to develop a fully automated spatial multiomics solution. This partnership aims to create a method for simultaneous identification of protein and RNA biomarkers on a single slide, offering panel design flexibility and facilitating comprehensive disease research.
- In 2021, NanoString Technologies, Inc. initiated the Technology Access Program (TAP), offering tissue sample analysis using the Spatial Molecular Imager platform and GeoMx Digital Spatial Profiler. This program expands spatial biology applications in the region.
Reasons to Purchase this Report:
- Comprehensive market segmentation analysis incorporating qualitative and quantitative research, considering the impact of economic and policy factors.
- In-depth regional and country-level analysis, examining the demand and supply dynamics that influence market growth.
- Market size in USD million and volume in million units provided for each segment and sub-segment.
- Detailed competitive landscape, including market share of major players, recent projects, and strategies implemented over the past five years.
- Comprehensive company profiles encompassing product offerings, key financial information, recent developments, SWOT analysis, and employed strategies by major market players.
Spatial OMICS Market Players
- NanoString Technologies, Inc.
- Illumina, Inc.
- 10x Genomics, Inc.
- Akoya Biosciences, Inc.
- Visiopharm A/S
- GE Healthcare
- Fluidigm Corporation
- Advanced Cell Diagnostics, Inc.
- PerkinElmer, Inc.
- ZEISS Group
- RareCyte, Inc.
- Bio-Rad Laboratories, Inc.
- ImaBiotech
- Indica Labs, Inc.
- Ultivue, Inc.
Segments Covered in the Report
By Application
- Diagnostics
- Translation Research
- Drug Discovery and Development
- Single Cell Analysis
- Cell Biology
- Other
By Solution Type
- Instruments
- Consumables
- Software
By Sample
- DNA
- RNA
- Protein
By End Users
- Academic and Research Institutions
- Biopharmaceutical & Biotechnological Companies
- Contract Research Organization
- Other
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Spatial OMICS Market
5.1. COVID-19 Landscape: Spatial OMICS Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Spatial OMICS Market, By Application
8.1. Spatial OMICS Market Revenue and Volume Forecast, by Application, 2023-2032
8.1.1. Diagnostics
8.1.1.1. Market Revenue and Volume Forecast (2020-2032)
8.1.2. Translation Research
8.1.2.1. Market Revenue and Volume Forecast (2020-2032)
8.1.3. Drug Discovery and Development
8.1.3.1. Market Revenue and Volume Forecast (2020-2032)
8.1.4. Single Cell Analysis
8.1.4.1. Market Revenue and Volume Forecast (2020-2032)
8.1.5. Cell Biology
8.1.5.1. Market Revenue and Volume Forecast (2020-2032)
8.1.6. Other
8.1.6.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 9. Global Spatial OMICS Market, By Solution Type
9.1. Spatial OMICS Market Revenue and Volume Forecast, by Solution Type, 2023-2032
9.1.1. Instruments
9.1.1.1. Market Revenue and Volume Forecast (2020-2032)
9.1.2. Consumables
9.1.2.1. Market Revenue and Volume Forecast (2020-2032)
9.1.3. Software
9.1.3.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 10. Global Spatial OMICS Market, By Sample
10.1. Spatial OMICS Market Revenue and Volume Forecast, by Sample, 2023-2032
10.1.1. DNA
10.1.1.1. Market Revenue and Volume Forecast (2020-2032)
10.1.2. RNA
10.1.2.1. Market Revenue and Volume Forecast (2020-2032)
10.1.3. Protein
10.1.3.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 11. Global Spatial OMICS Market, By End Users
11.1. Spatial OMICS Market Revenue and Volume Forecast, by End Users, 2023-2032
11.1.1. Academic and Research Institutions
11.1.1.1. Market Revenue and Volume Forecast (2020-2032)
11.1.2. Biopharmaceutical & Biotechnological Companies
11.1.2.1. Market Revenue and Volume Forecast (2020-2032)
11.1.3. Contract Research Organization
11.1.3.1. Market Revenue and Volume Forecast (2020-2032)
11.1.4. Other
11.1.4.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 12. Global Spatial OMICS Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Volume Forecast, by Application (2020-2032)
12.1.2. Market Revenue and Volume Forecast, by Solution Type (2020-2032)
12.1.3. Market Revenue and Volume Forecast, by Sample (2020-2032)
12.1.4. Market Revenue and Volume Forecast, by End Users (2020-2032)
12.1.5. U.S.
12.1.5.1. Market Revenue and Volume Forecast, by Application (2020-2032)
12.1.5.2. Market Revenue and Volume Forecast, by Solution Type (2020-2032)
12.1.5.3. Market Revenue and Volume Forecast, by Sample (2020-2032)
12.1.5.4. Market Revenue and Volume Forecast, by End Users (2020-2032)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Volume Forecast, by Application (2020-2032)
12.1.6.2. Market Revenue and Volume Forecast, by Solution Type (2020-2032)
12.1.6.3. Market Revenue and Volume Forecast, by Sample (2020-2032)
12.1.6.4. Market Revenue and Volume Forecast, by End Users (2020-2032)
12.2. Europe
12.2.1. Market Revenue and Volume Forecast, by Application (2020-2032)
12.2.2. Market Revenue and Volume Forecast, by Solution Type (2020-2032)
12.2.3. Market Revenue and Volume Forecast, by Sample (2020-2032)
12.2.4. Market Revenue and Volume Forecast, by End Users (2020-2032)
12.2.5. UK
12.2.5.1. Market Revenue and Volume Forecast, by Application (2020-2032)
12.2.5.2. Market Revenue and Volume Forecast, by Solution Type (2020-2032)
12.2.5.3. Market Revenue and Volume Forecast, by Sample (2020-2032)
12.2.5.4. Market Revenue and Volume Forecast, by End Users (2020-2032)
12.2.6. Germany
12.2.6.1. Market Revenue and Volume Forecast, by Application (2020-2032)
12.2.6.2. Market Revenue and Volume Forecast, by Solution Type (2020-2032)
12.2.6.3. Market Revenue and Volume Forecast, by Sample (2020-2032)
12.2.6.4. Market Revenue and Volume Forecast, by End Users (2020-2032)
12.2.7. France
12.2.7.1. Market Revenue and Volume Forecast, by Application (2020-2032)
12.2.7.2. Market Revenue and Volume Forecast, by Solution Type (2020-2032)
12.2.7.3. Market Revenue and Volume Forecast, by Sample (2020-2032)
12.2.7.4. Market Revenue and Volume Forecast, by End Users (2020-2032)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Volume Forecast, by Application (2020-2032)
12.2.8.2. Market Revenue and Volume Forecast, by Solution Type (2020-2032)
12.2.8.3. Market Revenue and Volume Forecast, by Sample (2020-2032)
12.2.8.4. Market Revenue and Volume Forecast, by End Users (2020-2032)
12.3. APAC
12.3.1. Market Revenue and Volume Forecast, by Application (2020-2032)
12.3.2. Market Revenue and Volume Forecast, by Solution Type (2020-2032)
12.3.3. Market Revenue and Volume Forecast, by Sample (2020-2032)
12.3.4. Market Revenue and Volume Forecast, by End Users (2020-2032)
12.3.5. India
12.3.5.1. Market Revenue and Volume Forecast, by Application (2020-2032)
12.3.5.2. Market Revenue and Volume Forecast, by Solution Type (2020-2032)
12.3.5.3. Market Revenue and Volume Forecast, by Sample (2020-2032)
12.3.5.4. Market Revenue and Volume Forecast, by End Users (2020-2032)
12.3.6. China
12.3.6.1. Market Revenue and Volume Forecast, by Application (2020-2032)
12.3.6.2. Market Revenue and Volume Forecast, by Solution Type (2020-2032)
12.3.6.3. Market Revenue and Volume Forecast, by Sample (2020-2032)
12.3.6.4. Market Revenue and Volume Forecast, by End Users (2020-2032)
12.3.7. Japan
12.3.7.1. Market Revenue and Volume Forecast, by Application (2020-2032)
12.3.7.2. Market Revenue and Volume Forecast, by Solution Type (2020-2032)
12.3.7.3. Market Revenue and Volume Forecast, by Sample (2020-2032)
12.3.7.4. Market Revenue and Volume Forecast, by End Users (2020-2032)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Volume Forecast, by Application (2020-2032)
12.3.8.2. Market Revenue and Volume Forecast, by Solution Type (2020-2032)
12.3.8.3. Market Revenue and Volume Forecast, by Sample (2020-2032)
12.3.8.4. Market Revenue and Volume Forecast, by End Users (2020-2032)
12.4. MEA
12.4.1. Market Revenue and Volume Forecast, by Application (2020-2032)
12.4.2. Market Revenue and Volume Forecast, by Solution Type (2020-2032)
12.4.3. Market Revenue and Volume Forecast, by Sample (2020-2032)
12.4.4. Market Revenue and Volume Forecast, by End Users (2020-2032)
12.4.5. GCC
12.4.5.1. Market Revenue and Volume Forecast, by Application (2020-2032)
12.4.5.2. Market Revenue and Volume Forecast, by Solution Type (2020-2032)
12.4.5.3. Market Revenue and Volume Forecast, by Sample (2020-2032)
12.4.5.4. Market Revenue and Volume Forecast, by End Users (2020-2032)
12.4.6. North Africa
12.4.6.1. Market Revenue and Volume Forecast, by Application (2020-2032)
12.4.6.2. Market Revenue and Volume Forecast, by Solution Type (2020-2032)
12.4.6.3. Market Revenue and Volume Forecast, by Sample (2020-2032)
12.4.6.4. Market Revenue and Volume Forecast, by End Users (2020-2032)
12.4.7. South Africa
12.4.7.1. Market Revenue and Volume Forecast, by Application (2020-2032)
12.4.7.2. Market Revenue and Volume Forecast, by Solution Type (2020-2032)
12.4.7.3. Market Revenue and Volume Forecast, by Sample (2020-2032)
12.4.7.4. Market Revenue and Volume Forecast, by End Users (2020-2032)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Volume Forecast, by Application (2020-2032)
12.4.8.2. Market Revenue and Volume Forecast, by Solution Type (2020-2032)
12.4.8.3. Market Revenue and Volume Forecast, by Sample (2020-2032)
12.4.8.4. Market Revenue and Volume Forecast, by End Users (2020-2032)
12.5. Latin America
12.5.1. Market Revenue and Volume Forecast, by Application (2020-2032)
12.5.2. Market Revenue and Volume Forecast, by Solution Type (2020-2032)
12.5.3. Market Revenue and Volume Forecast, by Sample (2020-2032)
12.5.4. Market Revenue and Volume Forecast, by End Users (2020-2032)
12.5.5. Brazil
12.5.5.1. Market Revenue and Volume Forecast, by Application (2020-2032)
12.5.5.2. Market Revenue and Volume Forecast, by Solution Type (2020-2032)
12.5.5.3. Market Revenue and Volume Forecast, by Sample (2020-2032)
12.5.5.4. Market Revenue and Volume Forecast, by End Users (2020-2032)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Volume Forecast, by Application (2020-2032)
12.5.6.2. Market Revenue and Volume Forecast, by Solution Type (2020-2032)
12.5.6.3. Market Revenue and Volume Forecast, by Sample (2020-2032)
12.5.6.4. Market Revenue and Volume Forecast, by End Users (2020-2032)
Chapter 13. Company Profiles
13.1. NanoString Technologies, Inc.
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Illumina, Inc.
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. 10x Genomics, Inc.
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Akoya Biosciences, Inc.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Visiopharm A/S
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. GE Healthcare
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Fluidigm Corporation
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Advanced Cell Diagnostics, Inc.
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. PerkinElmer, Inc.
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. ZEISS Group
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
Blog: https://www.expresswebwire.com/
Blog: https://www.uswebwire.com/
